Loading clinical trials...
Loading clinical trials...
Retrospective Cohort Study Comparing a Novel Silicone Gel Wound Dressing vs Standard of Care in the Treatment of Radiation Dermatitis
Routinely collected data on radiation-induced skin toxicity from 2010 to 2022 will be retrospectively analyzed. Data will be split into two cohorts: patients that received 1) StrataXRT and 2) standard of care. The incidence of grade ≥ 2 radiation dermatitis, the time to onset of grade ≥ 2 radiation dermatitis, the radiation dose at onset of grade ≥ 2 radiation dermatitis, the incidence of moist desquamation and the number of treatment interruptions will be compared between the cohorts.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of California
Los Angeles, California, United States
Start Date
May 1, 2023
Primary Completion Date
September 30, 2023
Completion Date
December 31, 2023
Last Updated
February 1, 2024
344
ACTUAL participants
StrataXRT
DEVICE
Calendula
DRUG
Aquaphor
DRUG
Lead Sponsor
Stratpharma AG
NCT07081074
NCT03394417
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04173247